Literature DB >> 36238265

Resveratrol inhibits TRAF6/PTCH/SMO signal and regulates prostate cancer progression.

Jianping Li1, Ziming Wang1, Hecheng Li1, Jun Cao1, Ning Nan1, Xiaoqiang Zhai1, Ying Liu1, Tie Chong1.   

Abstract

Prostate cancer (PC) is one of the most common types of cancers among men, referring to the uncontrolled growth of the prostate gland. It is increasingly recognized that the interaction of the glioma-associated oncogene (GLI) pathway and androgen receptor affects PC progression. Nevertheless, the effects of resveratrol on PC progression via Hedgehog (HH) signaling remain unexplored. In this study, the castration-sensitive and castration-resistant xenograft models in mice are systematically established using two different PC cell lines (LNCaP and PC-3). Further, the Western blotting, immunohistochemistry, MTT, Transwell, and RT-qPCR analyses are performed to verify the mechanistic views of resveratrol on PC and HH signals in vitro and in vivo. Resveratrol showed epithelial-mesenchymal transition (EMT) progression, inhibiting the tumor size and expression levels of vimentin, vascular endothelial growth factor (VEGF), and matrix metalloproteinases (MMP) 7, as well as upregulating the expression profiles the E-cadherin and Annexin 2. Moreover, resveratrol inhibited the hedgehog (HH) signals and tumor necrosis factor receptor (TNFR)-associated factor 6 (TRAF6) levels exhibiting the therapeutic action on castration-sensitive and castration-resistant PC cell lines. In summary, the overexpression of TRAF6 enhanced the viability and EMT progression of cancer cells. The resveratrol could alleviate the TRAF6 effect and regulate the HH signal to affect PC progression. Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-022-00544-0.
© The Author(s), under exclusive licence to Springer Nature B.V. 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Entities:  

Keywords:  Hedgehog; Prostate cancer; Resveratrol; TRAF6

Year:  2022        PMID: 36238265      PMCID: PMC9525528          DOI: 10.1007/s10616-022-00544-0

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.040


  25 in total

1.  Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts.

Authors:  Steven J Dias; Kun Li; Agnes M Rimando; Swati Dhar; Cassia S Mizuno; Alan D Penman; Anait S Levenson
Journal:  Prostate       Date:  2013-05-08       Impact factor: 4.104

2.  Dual regulation of decorin by androgen and Hedgehog signaling during prostate morphogenesis.

Authors:  Monica Montano; Kenneth H Dinnon; Logan Jacobs; William Xiang; Renato V Iozzo; Wade Bushman
Journal:  Dev Dyn       Date:  2018-02-19       Impact factor: 3.780

3.  Resveratrol attenuates neuroinflammation after deep hypothermia with circulatory arrest in rats.

Authors:  Qiang Chen; Kai-Peng Sun; Jiang-Shan Huang; Zeng-Chun Wang; Zhi-Nuan Hong
Journal:  Brain Res Bull       Date:  2019-12-14       Impact factor: 4.077

4.  Gli activation by the estrogen receptor in breast cancer cells: Regulation of cancer cell growth by Gli3.

Authors:  Shabnam Massah; Jane Foo; Na Li; Sarah Truong; Mannan Nouri; Lishi Xie; Gail S Prins; Ralph Buttyan
Journal:  Mol Cell Endocrinol       Date:  2020-12-25       Impact factor: 4.102

5.  Polymeric Micellar Delivery of Novel Microtubule Destabilizer and Hedgehog Signaling Inhibitor for Treating Chemoresistant Prostate Cancer.

Authors:  Ruinan Yang; Hao Chen; Dawei Guo; Yuxiang Dong; Duane D Miller; Wei Li; Ram I Mahato
Journal:  J Pharmacol Exp Ther       Date:  2019-04-17       Impact factor: 4.030

6.  Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration.

Authors:  Farjana Yeasmin Khusbu; Xi Zhou; Mridul Roy; Fang-Zhi Chen; Qian Cao; Han-Chun Chen
Journal:  Int J Biochem Cell Biol       Date:  2019-11-09       Impact factor: 5.085

7.  Smoothened stabilizes and protects TRAF6 from degradation: A novel non-canonical role of smoothened with implications in lymphoma biology.

Authors:  Changju Qu; Kranthi Kunkalla; Amineh Vaghefi; John K Frederiksen; Yadong Liu; Jennifer R Chapman; Marzenna Blonska; Leon Bernal-Mizrachi; Juan Pablo Alderuccio; Izidore S Lossos; Ralf Landgraf; Francisco Vega
Journal:  Cancer Lett       Date:  2018-08-27       Impact factor: 8.679

Review 8.  The resurgence of estrogens in the treatment of castration-resistant prostate cancer.

Authors:  H Krishna Moorthy; G G Laxman Prabhu; P Venugopal
Journal:  Indian J Urol       Date:  2019 Jul-Sep

9.  TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer.

Authors:  Karthik Aripaka; Shyam Kumar Gudey; Guangxiang Zang; Alexej Schmidt; Samaneh Shabani Åhrling; Lennart Österman; Anders Bergh; Jonas von Hofsten; Marene Landström
Journal:  EBioMedicine       Date:  2019-06-28       Impact factor: 8.143

Review 10.  Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways.

Authors:  Milad Ashrafizadeh; Hossein Rafiei; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Cancer Cell Int       Date:  2021-01-21       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.